These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 11379415)

  • 1. New disease modifying agents in adult rheumatoid arthritis.
    Koh ET
    Ann Acad Med Singap; 2001 Mar; 30(2):170-3. PubMed ID: 11379415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness.
    Chen YF; Jobanputra P; Barton P; Jowett S; Bryan S; Clark W; Fry-Smith A; Burls A
    Health Technol Assess; 2006 Nov; 10(42):iii-iv, xi-xiii, 1-229. PubMed ID: 17049139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Etanercept, infliximab, and leflunomide in established rheumatoid arthritis: clinical experience using a structured follow up programme in southern Sweden.
    Geborek P; Crnkic M; Petersson IF; Saxne T;
    Ann Rheum Dis; 2002 Sep; 61(9):793-8. PubMed ID: 12176803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment options for rheumatoid arthritis: celecoxib, leflunomide, etanercept, and infliximab.
    Luong BT; Chong BS; Lowder DM
    Ann Pharmacother; 2000 Jun; 34(6):743-60. PubMed ID: 10860137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [New drugs and treatment strategies for rheumatoid arthritis].
    Fantini F
    Recenti Prog Med; 2003 Sep; 94(9):361-79. PubMed ID: 12942798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preliminary evaluation in rheumatoid arthritis activity in patients treated with TNF-alpha blocker plus methotrexate versus methotrexate or leflunomide alone.
    Wisłowska M; Jakubicz D
    Rheumatol Int; 2007 May; 27(7):641-7. PubMed ID: 17235556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative effectiveness of tumour necrosis factor alpha inhibitors in combination with either methotrexate or leflunomide.
    Strangfeld A; Hierse F; Kekow J; von Hinueber U; Tony HP; Dockhorn R; Listing J; Zink A
    Ann Rheum Dis; 2009 Dec; 68(12):1856-62. PubMed ID: 19126559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in the medical management of rheumatoid arthritis.
    Scott DL
    Hosp Med; 2002 May; 63(5):294-7. PubMed ID: 12066349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of rheumatoid arthritis by inhibition of tumor necrosis factor with infliximab or etanercept].
    Tijhuis GJ; van de Putte LB; Breedveld FC
    Ned Tijdschr Geneeskd; 2001 Sep; 145(39):1880-5. PubMed ID: 11605312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rational use of new and existing disease-modifying agents in rheumatoid arthritis.
    Kremer JM
    Ann Intern Med; 2001 Apr; 134(8):695-706. PubMed ID: 11304108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progress in the treatment of rheumatoid arthritis.
    Pisetsky DS; St Clair EW
    JAMA; 2001 Dec; 286(22):2787-90. PubMed ID: 11735734
    [No Abstract]   [Full Text] [Related]  

  • 12. TNF blockade in the treatment of rheumatoid arthritis: infliximab versus etanercept.
    Mikuls TR; Moreland LW
    Expert Opin Pharmacother; 2001 Jan; 2(1):75-84. PubMed ID: 11336570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in the treatment of rheumatoid arthritis.
    Strand V
    Clin Cornerstone; 1999; 2(2):38-50. PubMed ID: 10689543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "Stepping-up" from methotrexate: a systematic review of randomised placebo controlled trials in patients with rheumatoid arthritis with an incomplete response to methotrexate.
    Hochberg MC; Tracy JK; Flores RH
    Ann Rheum Dis; 2001 Nov; 60 Suppl 3(Suppl 3):iii51-4. PubMed ID: 11890654
    [No Abstract]   [Full Text] [Related]  

  • 15. New therapeutic approaches to the management of rheumatoid arthritis.
    Hughes LB; Moreland LW
    BioDrugs; 2001; 15(6):379-93. PubMed ID: 11520249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New and future drug therapies for rheumatoid arthritis.
    Simon LS; Yocum D
    Rheumatology (Oxford); 2000 Jun; 39 Suppl 1():36-42. PubMed ID: 11001378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumour necrosis factor-alpha blockade: a new era for effective management of rheumatoid arthritis.
    Hamilton K; Clair EW
    Expert Opin Pharmacother; 2000 Jul; 1(5):1041-52. PubMed ID: 11249494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drugs that block tumour necrosis factor: experience in patients with rheumatoid arthritis.
    Moreland LW
    Pharmacoeconomics; 2004; 22(2 Suppl 1):39-53. PubMed ID: 15157003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New drugs for the treatment of rheumatoid arthritis.
    Schuna AA; Megeff C
    Am J Health Syst Pharm; 2000 Feb; 57(3):225-34. PubMed ID: 10674776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interpreting radiographic data in rheumatoid arthritis.
    Ory PA
    Ann Rheum Dis; 2003 Jul; 62(7):597-604. PubMed ID: 12810418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.